Sanofi-Aventis Deutschland GmbH

Where the EU money came from

Funding by EU programme. Amounts are Sanofi-Aventis Deutschland GmbH's own share of each project, not the project's full budget.

Projects

50 EU-funded projects, newest first. Sanofi-Aventis Deutschland GmbH led 3 of them as coordinator. Each links to the official record.

• PFAROSPartner

  Driving Sustainable Innovation to Minimise PFAS in European Healthcare

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• FORTIFYAssociated partner

  FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• EXIT-CVDPartner

  EXIT-CVD

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• UNLIMITEDAssociated partner

  UNderstanding Lipid ImmunoMetabolIsm To trEat Disease

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• EIPOD-LinCAssociated partner

  EMBL Interdisciplinary Postdocs - Life in Context

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• PROBEAssociated partner

  Patient Relevant Osteoarthritis endpoints using Big data Evaluation

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• BRIDGEAssociated partner

  Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

  Horizon Europe · 2025–2028 · Project on CORDIS ↗
• CHITOCATAssociated partner

  Development of Chitosan-based Immobilized Catalysts for H/D Exchange in Continuous Flow Systems

  Horizon Europe · 2025–2027 · Project on CORDIS ↗
• RealiseDAssociated partner

  Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• PIAPartner

  Photocatalytic Industrial Applications

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €261ktheir share
• PharmEcoPartner

  Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing

  Horizon Europe · 2024–2030 · Project on CORDIS ↗
• MC4DDPartner

  Macrocycles for Drug Discovery

  Horizon Europe · 2024–2028 · Project on CORDIS ↗

  €261ktheir share
• NHPigAssociated partner

  Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• VICT3RPartner

  Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• AD-RIDDLEAssociated partner

  REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENT

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• EDENT1FIPartner

  European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• AiRPaDDPartner

  Advancing Reaction Platforms for Drug Discovery

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €261ktheir share
• ISOBIOTICSPartner

  Isotopic Labeling of Biotherapeutics

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €521ktheir share
• RealHOPEPartner

  Real World Handling of Protein Drugs - Exploration, Evaluation and Education

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗
• INNODIA HARVESTPartner

  Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

  Horizon 2020 · 2020–2024 · Project on CORDIS ↗
• ImmUniversePartner

  Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• 3TRPartner

  Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

  Horizon 2020 · 2019–2028 · Project on CORDIS ↗
• BIOMAPPartner

  Biomarkers in Atopic Dermatitis and Psoriasis

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• ESCulabPartner

  European Screening Centre; Unique Library for Attractive Biology

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗
• iConsensusPartner

  Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

  Horizon 2020 · 2018–2022 · Project on CORDIS ↗
• Hypo-RESOLVEPartner

  Hypoglycaemia - REdefining SOLutions for better liVEs

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗
• LITMUSPartner

  Liver Investigation: Testing Marker Utility in Steatohepatitis

  Horizon 2020 · 2017–2024 · Project on CORDIS ↗
• RTCurePartner

  Rheuma Tolerance for Cure

  Horizon 2020 · 2017–2023 · Project on CORDIS ↗
• eTRANSAFEPartner

  Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

  Horizon 2020 · 2017–2023 · Project on CORDIS ↗
• IB4SD-TRISTANPartner

  Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

  Horizon 2020 · 2017–2024 · Project on CORDIS ↗
• BEAt-DKDPartner

  Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

  Horizon 2020 · 2016–2023 · Project on CORDIS ↗
• RHAPSODYPartner

  Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

  Horizon 2020 · 2016–2021 · Project on CORDIS ↗
• MAST4HEALTHPartner

  Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).

  Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  €81ktheir share
• ISOTOPICSPartner

  ISOTOPIC LABELING FOR DRUG INNOVATION

  Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  €249ktheir share
• INNODIAPartner

  Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

  Horizon 2020 · 2015–2023 · Project on CORDIS ↗
• BiorapidPartner

  Rapid Bioprocess Development

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  €249ktheir share
• COSSHNETPartner

  Complementary Synthetic Strategies toward Heterocyclic Boronates

  FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗
• EUC²LIDPartner

  European Lead Factory

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
• COMPACTCoordinator

  Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
• K4DDPartner

  Kinetics for Drug Discovery (K4DD)

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Novo Nordisk A/SDenmark · 22 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 19 shared projects
• Novartis Pharma AGSwitzerland · 17 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 17 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 17 shared projects
• Astrazeneca ABSweden · 16 shared projects
• Janssen Pharmaceutica NVBelgium · 15 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 14 shared projects
• Pfizer LimitedUnited Kingdom · 14 shared projects
• Karolinska InstitutetSweden · 12 shared projects
• Bayer AktiengesellschaftGermany · 12 shared projects
• Merck Kommanditgesellschaft Auf AktienGermany · 12 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 12 shared projects
• Ucb BiopharmaBelgium · 11 shared projects
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 10 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 10 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• RNA
• animal and dairy science
• artificial intelligence
• big data
• biomolecules
• bioreactors
• business models
• cardiovascular diseases
• catalysis
• civil society
• computational science
• data mining
• data processing
• data science